Company Filing History:

8 out of 33

Idun Pharmaceuticals, Inc.

patents

1 out of 234

Bristol-myers Squibb Pharma Company

patents

1 out of 832,680

Other

patents

Years Active: 1999-2004

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6825208 - Tetrahydroquinoline derivatives as antithrombotic agents (2004-11-30),

2. 6693096 - Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors (2004-02-17),

3. 6610683 - Treatment of infectious disease using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors (2003-08-26),

4. 6531467 - Inhibition of inflammation using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors (2003-03-11),

5. 6528506 - Inhibition of apoptosis using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors (2003-03-04),

6. 6489353 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases (2002-12-03),

7. 6200969 - Inhibition of apoptosis using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors (2001-03-13),

8. 6184244 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases (2001-02-06),

9. 5877197 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors (1999-03-02),

10. 5869519 - C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors (1999-02-09),

Title: Xu Bai: Innovator in Antithrombotic and Inflammation Treatments

Introduction

Xu Bai is a prominent inventor based in Carlsbad, California, known for his significant contributions to the field of pharmaceuticals. He holds a total of 10 patents, showcasing his innovative approach to developing new therapeutic agents.

Latest Patents

Among his latest patents, Xu Bai has developed tetrahydroquinoline derivatives as antithrombotic agents. This invention focuses on tetracyclic tetrahydroquinoline compounds, which serve as selective inhibitors of serine protease enzymes, particularly factor VIIa. The patent also includes pharmaceutical compositions containing these compounds and methods for their use as anticoagulant agents to modulate the coagulation cascade. Another notable patent addresses the treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors. This invention provides methods and compositions aimed at preventing and treating inflammation-related disorders by suppressing the activity of specific proteases.

Career Highlights

Xu Bai has worked with various companies, including Idun Pharmaceuticals, Inc. His work has significantly impacted the development of new therapeutic strategies in the pharmaceutical industry.

Collaborations

Throughout his career, Xu Bai has collaborated with notable professionals, including Lawrence C. Fritz and Kevin J. Tomaselli. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Xu Bai's contributions to the field of pharmaceuticals, particularly in antithrombotic and inflammation treatments, highlight his role as a leading inventor. His innovative patents and collaborations continue to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.